NAYAバイオサイエンスのニュース一覧

NAYAバイオサイエンス | 10-Q：Q3 2024 四半期報告書

SEC11/20 05:22

NAYAバイオサイエンス | 10-Q/A：四半期報告書(訂正)

SEC11/20 05:17

NAYAバイオサイエンス | 10-K/A：有価証券報告書(訂正)

SEC11/20 05:13

NAYA Biosciences Announces Initiation of Phase 1/2a Clinical Trial for Its GPC3-targeted NK Engager Bispecific Antibody in Patients With Hepatocellular Carcinoma

GlobeNewswire10/24 21:00

Invo BioScience Will Begin Trading Under New Symbol NAYA at Market Open on Oct 22 >INVO

Dow Jones10/21 21:01

What Happened With Invo BioScience Stock Today?

Benzinga10/15 05:38

12 Health Care Stocks Moving In Monday's Intraday Session

Benzinga10/15 00:30

Press Release: INVO Bioscience and NAYA Biosciences Close Merger, Combined Company to Operate as NAYA Biosciences (NASDAQ: NAYA)

Dow Jones10/14 21:18

INVO BioScience GAAP EPS of -$0.62, Revenue of $1.84M

Seeking Alpha08/16 00:14

INVO バイオサイエンス | 8-K：INVOは、収益が481％増加し、調整後EBITDAが110万ドル向上し、2024年第2四半期の記録的な業績を報告しています

SEC08/15 04:14

INVO バイオサイエンス | 10-Q：Q2 2024 四半期報告書

SEC08/14 21:05

Invo BioScience 2Q Rev $1.84M >INVO

Dow Jones08/14 21:00

Invo BioScience 2Q Loss $2.2M >INVO

Dow Jones08/14 21:00

Why Merck Shares Are Trading Lower By 10%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session

Benzinga07/31 01:53

Why Pitney Bowes Shares Are Trading Higher By Over 12%; Here Are 20 Stocks Moving Premarket

Benzinga07/29 17:26

INVO Bioscience Files for $100M Mixed Shelf

Seeking Alpha05/22 04:52

INNO BioScience Shares Are Trading Higher After the Company Reported a Year-over-year Increase in Q1 EPS Results.

Benzinga05/16 19:56

INVO バイオサイエンス | 8-K：INVOレポート、2024年第1四半期の業績は過去最高を記録し、調整後EBITDAの改善により収益は353％増加しました

SEC05/16 04:57

INVO Bioscience Q1 EPS $(0.42), Sales $1.58M Up From $348.02K YoY

Benzinga05/16 04:45

Invo BioScience 1Q Rev $1.58M >INVO

Dow Jones05/16 04:18